@FierceBiotech: ICYMI yesterday: Bristol-Myers fires off a lawsuit to sideline R&D defector headed to rival AstraZeneca. Article | Follow @FierceBiotech
@JohnCFierce: Top #ASCO15 story for @FierceBiotech: Genentech's PD-L1 breakthrough star 'atezo' positioned to vault ahead on cancer. Story | Follow @JohnCFierce
@DamianFierce: Kinda feels like $JUNO Googled "CAR-T" and is gradually buying the whole first page of results. Release | Story | Follow @DamianFierce
> Acorda Therapeutics ($ACOR) has paused a Phase Ib trial on the heart failure treatment cimaglermin alfa after observing kidney damage in some patients. More
> AstraZeneca ($AZN) plans to decide in a "few weeks" whether to carry on with brodalumab, an investigational psoriasis treatment whose ties to suicidal thoughts led partner Amgen ($AMGN) to walk away from the project last month. News
> Novartis' ($NVS) anti-inflammatory treatment secukinumab succeeded in a Phase III study in ankylosing spondylitis, the company's next desired indication after winning approval in psoriasis. Story
Medical Device News
@FierceMedDev: ICYMI: Fierce exclusive: Zimmer to cut staff, close its dental headquarters following $13B merger with Biomet. Report | Follow @FierceMedDev
@VarunSaxena2: Hospitals tell feds that they can do more to support unique device ID. Story | Follow @VarunSaxena2
@EmilyWFierce: ICYMI: Otsuka faces the music for generic Abilify, loses battle with FDA. Article | Follow @EmilyWFierce
> Prenatal Dx player Natera looks to do an up to $100M IPO to expand, move into liquid biopsy. More
> Israeli startup unveils cloud-based mobile fetal monitor. Article
Pharma News
@FiercePharma: ICYMI: Look for orphan drugs to keep fueling M&A, Moody's says. Report | Follow @FiercePharma
@CarlyHFierce: Valeant plots big DTC push for Xifaxan while rival Actavis drug waits on DEA. More from FiercePharmaMarketing | Follow @CarlyHFierce
> Mylan deal target Perrigo bags GSK, Novartis consumer meds. News
> Mylan challenges Teva to put up a bid--or shut up and let it buy Perrigo. Report
Drug Delivery News
> NeuroVive's cardiology candidate fails to meet its endpoint. Item
> Cedars-Sinai team develops delivery-Dx combo nanomed for brain cancer. More
> Reassessment of trial data at ASCO to benefit Sirtex's cancer-fighting microspheres. Report
> Novartis partners with 'robotic' pillmaker in oral biologic race. Story
> FDA approves Lilly's reformulated insulin to foster patient convenience. Article
Pharma Manufacturing News
> Myanmar Pharma plans $30M upgrade to compete with Indian imports. Item
> South Korea's Green Cross building $240M plasma plant in Canada. More
> Hospira again shipping ketorolac but U.S. faces many drug shortages. Story
> Wockhardt looks to get banned plants back online in 2016. Article
> Sources: Cipla, Lupin bid on UCB's Kremers Urban. Report
Pharma Asia News
> Leading Japan drug firms team up with AZ on parasitic disease research. News
> SK Biopharmaceuticals says Jazz-led sleep disorder PhIII candidate on the cards. Report
> Taiwan recalls Y.F. Chemical sodium chloride products on new contamination events. Article
> Cipla, Lupin in UCB U.S. generics bid as India-linked M&A heats up. More
> Novartis India gets reprieve from NPPA on fine for over-pricing drug. Story